Treace Medical Concepts Statistics
Total Valuation
TMCI has a market cap or net worth of $288.10 million. The enterprise value is $315.53 million.
| Market Cap | 288.10M |
| Enterprise Value | 315.53M |
Important Dates
The next confirmed earnings date is Friday, November 6, 2026, before market open.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TMCI has 65.03 million shares outstanding. The number of shares has increased by 2.71% in one year.
| Current Share Class | 65.03M |
| Shares Outstanding | 65.03M |
| Shares Change (YoY) | +2.71% |
| Shares Change (QoQ) | +0.71% |
| Owned by Insiders (%) | 26.44% |
| Owned by Institutions (%) | 39.40% |
| Float | 47.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.40 |
| Forward PS | 1.34 |
| PB Ratio | 4.25 |
| P/TBV Ratio | 5.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.90, with a Debt / Equity ratio of 1.08.
| Current Ratio | 2.90 |
| Quick Ratio | 1.80 |
| Debt / Equity | 1.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.23 |
Financial Efficiency
Return on equity (ROE) is -71.99% and return on invested capital (ROIC) is -21.77%.
| Return on Equity (ROE) | -71.99% |
| Return on Assets (ROA) | -17.33% |
| Return on Invested Capital (ROIC) | -21.77% |
| Return on Capital Employed (ROCE) | -38.49% |
| Weighted Average Cost of Capital (WACC) | 11.19% |
| Revenue Per Employee | $456,238 |
| Profits Per Employee | -$132,258 |
| Employee Count | 450 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 1.03 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.37% in the last 52 weeks. The beta is 1.49, so TMCI's price volatility has been higher than the market average.
| Beta (5Y) | 1.49 |
| 52-Week Price Change | -32.37% |
| 50-Day Moving Average | 4.43 |
| 200-Day Moving Average | 3.24 |
| Relative Strength Index (RSI) | 51.61 |
| Average Volume (20 Days) | 226,626 |
Short Selling Information
The latest short interest is 1.92 million, so 2.96% of the outstanding shares have been sold short.
| Short Interest | 1.92M |
| Short Previous Month | 1.98M |
| Short % of Shares Out | 2.96% |
| Short % of Float | 4.02% |
| Short Ratio (days to cover) | 8.36 |
Income Statement
In the last 12 months, TMCI had revenue of $205.31 million and -$59.52 million in losses. Loss per share was -$0.93.
| Revenue | 205.31M |
| Gross Profit | 163.12M |
| Operating Income | -53.72M |
| Pretax Income | -59.52M |
| Net Income | -59.52M |
| EBITDA | -46.35M |
| EBIT | -53.72M |
| Loss Per Share | -$0.93 |
Balance Sheet
The company has $45.62 million in cash and $73.05 million in debt, with a net cash position of -$27.43 million or -$0.42 per share.
| Cash & Cash Equivalents | 45.62M |
| Total Debt | 73.05M |
| Net Cash | -27.43M |
| Net Cash Per Share | -$0.42 |
| Equity (Book Value) | 67.74M |
| Book Value Per Share | 1.04 |
| Working Capital | 78.96M |
Cash Flow
In the last 12 months, operating cash flow was -$14.58 million and capital expenditures -$10.47 million, giving a free cash flow of -$25.05 million.
| Operating Cash Flow | -14.58M |
| Capital Expenditures | -10.47M |
| Depreciation & Amortization | 7.37M |
| Net Borrowing | 3.00M |
| Free Cash Flow | -25.05M |
| FCF Per Share | -$0.39 |
Margins
Gross margin is 79.45%, with operating and profit margins of -26.17% and -28.99%.
| Gross Margin | 79.45% |
| Operating Margin | -26.17% |
| Pretax Margin | -28.99% |
| Profit Margin | -28.99% |
| EBITDA Margin | -22.58% |
| EBIT Margin | -26.17% |
| FCF Margin | n/a |
Dividends & Yields
TMCI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.71% |
| Shareholder Yield | -2.71% |
| Earnings Yield | -20.91% |
| FCF Yield | -8.69% |
Analyst Forecast
The average price target for TMCI is $5.50, which is 24.15% higher than the current price. The consensus rating is "Hold".
| Price Target | $5.50 |
| Price Target Difference | 24.15% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 3.61% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMCI has an Altman Z-Score of -0.18 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.18 |
| Piotroski F-Score | 2 |